Case report: Recovery of hallucinations and cognitive impairment after administration of donepezil in a patient with schizophrenia and carbon monoxide poisoning | Canada Hyperbarics Skip to main content
Case Report Front Psychiatry 2022

Case report: Recovery of hallucinations and cognitive impairment after administration of donepezil in a patient with schizophrenia and carbon monoxide poisoning

Baek S, Kim J, Lee Y, Kim J, Kim S, Kim J — Front Psychiatry, 2022

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on a single patient with schizophrenia and carbon monoxide poisoning who experienced cognitive and psychotic symptom improvement after taking donepezil, following unsuccessful hyperbaric oxygen therapy.

What They Found

A 38-year-old male with schizophrenia developed delayed neurological sequelae after carbon monoxide poisoning. Despite receiving 10 sessions of hyperbaric oxygen therapy, his cognitive impairment persisted. However, after being administered 5-10 mg of donepezil, both his cognitive function and psychotic symptoms showed remarkable improvement.

What This Means for Canadian Patients

For Canadian patients experiencing delayed neurological sequelae and psychotic symptoms after carbon monoxide poisoning, this case suggests donepezil could be a potential treatment option, especially if other therapies like hyperbaric oxygen therapy are not effective for cognitive issues. It highlights the complexity of treating such cases and the need for individualized approaches to manage both cognitive and psychiatric symptoms.

Canadian Relevance

Although this study was not conducted in Canada, it covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.

Study Limitations

As a case report, this study describes the experience of only one patient, meaning its findings cannot be generalized to all individuals with similar conditions.

Was this summary helpful?

Study Details

Study Type Case Report
Category Neurological
Source Pubmed
PubMed ID 36465281
Year Published 2022
Journal Front Psychiatry

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.